Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

KyungAh Im

Showing results (11-20 of 73) with videos related to

Pageof 8
Sort By:
Journal of Hepatology|July 23, 2008
Prospective analysis of effector and regulatory CD4+ T cells in chronic HCV patients undergoing combination antiviral therapyJames R Burton, Jared Klarquist, KyungAh Im, et al.
The Journal of Infectious Diseases|November 19, 2003
Survival of human immunodeficiency virus-infected liver transplant recipientsMargaret V Ragni, Steven H Belle, KyungAh Im, et al.
JAMA|September 28, 2016
Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysisMichael G Silverman, Brian A Ference, Kyungah Im, et al.
Lancet (London, England)|November 13, 2020
Efficacy and safety of lowering LDL cholesterol in older patients: a systematic review and meta-analysis of randomised controlled trialsBaris Gencer, Nicholas A Marston, KyungAh Im, et al.
Circulation|September 19, 2019
Association Between Triglyceride Lowering and Reduction of Cardiovascular Risk Across Multiple Lipid-Lowering Therapeutic Classes: A Systematic Review and Meta-Regression Analysis of Randomized Controlled TrialsNicholas A Marston, Robert P Giugliano, KyungAh Im, et al.
Journal of the American College of Cardiology|January 25, 2020
Morphine and Cardiovascular Outcomes Among Patients With Non-ST-Segment Elevation Acute Coronary Syndromes Undergoing Coronary AngiographyRemo H M Furtado, José C Nicolau, Jianping Guo, et al.
Journal of the American Heart Association|October 12, 2017
Short Sleep Duration, Obstructive Sleep Apnea, Shiftwork, and the Risk of Adverse Cardiovascular Events in Patients After an Acute Coronary SyndromeLaura K Barger, Shantha M W Rajaratnam, Christopher P Cannon, et al.
European Journal of Preventive Cardiology|July 23, 2021
LDL-cholesterol lowering with evolocumab, and outcomes according to age and sex in patients in the FOURIER TrialPeter Sever, Ioanna Gouni-Berthold, Anthony Keech, et al.
Antimicrobial Agents and Chemotherapy|October 15, 2008
Polymorphism in the human major histocompatibility complex and early viral decline during treatment of chronic hepatitis CLeland J Yee, KyungAh Im, Abdus S Wahed, et al.
The American Journal of Cardiology|October 28, 2018
Prevalence and Outcomes of Polyvascular (Coronary, Peripheral, or Cerebrovascular) Disease in Patients With Diabetes Mellitus (From the SAVOR-TIMI 53 Trial)Jorge Antonio Gutierrez, Benjamin M Scirica, Marc P Bonaca, et al.
Pageof 8

Showing results (11-20 of 73) with videos related to

Sort By:
Pageof 8
Journal of Hepatology|July 23, 2008
Prospective analysis of effector and regulatory CD4+ T cells in chronic HCV patients undergoing combination antiviral therapyJames R Burton, Jared Klarquist, KyungAh Im, et al.
The Journal of Infectious Diseases|November 19, 2003
Survival of human immunodeficiency virus-infected liver transplant recipientsMargaret V Ragni, Steven H Belle, KyungAh Im, et al.
JAMA|September 28, 2016
Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysisMichael G Silverman, Brian A Ference, Kyungah Im, et al.
Lancet (London, England)|November 13, 2020
Efficacy and safety of lowering LDL cholesterol in older patients: a systematic review and meta-analysis of randomised controlled trialsBaris Gencer, Nicholas A Marston, KyungAh Im, et al.
Circulation|September 19, 2019
Association Between Triglyceride Lowering and Reduction of Cardiovascular Risk Across Multiple Lipid-Lowering Therapeutic Classes: A Systematic Review and Meta-Regression Analysis of Randomized Controlled TrialsNicholas A Marston, Robert P Giugliano, KyungAh Im, et al.
Journal of the American College of Cardiology|January 25, 2020
Morphine and Cardiovascular Outcomes Among Patients With Non-ST-Segment Elevation Acute Coronary Syndromes Undergoing Coronary AngiographyRemo H M Furtado, José C Nicolau, Jianping Guo, et al.
Journal of the American Heart Association|October 12, 2017
Short Sleep Duration, Obstructive Sleep Apnea, Shiftwork, and the Risk of Adverse Cardiovascular Events in Patients After an Acute Coronary SyndromeLaura K Barger, Shantha M W Rajaratnam, Christopher P Cannon, et al.
European Journal of Preventive Cardiology|July 23, 2021
LDL-cholesterol lowering with evolocumab, and outcomes according to age and sex in patients in the FOURIER TrialPeter Sever, Ioanna Gouni-Berthold, Anthony Keech, et al.
Antimicrobial Agents and Chemotherapy|October 15, 2008
Polymorphism in the human major histocompatibility complex and early viral decline during treatment of chronic hepatitis CLeland J Yee, KyungAh Im, Abdus S Wahed, et al.
The American Journal of Cardiology|October 28, 2018
Prevalence and Outcomes of Polyvascular (Coronary, Peripheral, or Cerebrovascular) Disease in Patients With Diabetes Mellitus (From the SAVOR-TIMI 53 Trial)Jorge Antonio Gutierrez, Benjamin M Scirica, Marc P Bonaca, et al.
Pageof 8